group buying, page-38

I agree that sophs wont be involved. After having all previous share issues ratified at AGM, we are now free to issue the full 15% again without approval.

But you need to ask yourself is 15% enough?

Obviously depends on how long they wait and what the sp is at the time, but realistically its not enough. They could raise that amount or issue 100mil shares as suggested earlier in the thread. But what would it prove?

Lets say the sp is a bit higher, they then offer a discount to sophs, pay some placement fees. Whats left? $1mil odd.

No point imo. It would all go to Crossmark for fees and a decent but not great advertising campaign. Well a short one anyway. Then put Tripeptofen on back burner and further expansion lines etc until funds come in from sales?

Much better to do a big rights issue very similar to the January 2010 one. Probably even similar in that it will follow a sudden rise in sp and will include free options.

One last cr imo. Raise a large amount, let people average down. Then a massive marketing attack and accelerated expansion and research.

If we continue to raise small amount and drag our feet, this will just drag on forever and no meaningful money will be made. But JP will keep earning a salary.

"Potentially some form of different capital raising then what we have seen in the past. "

Personally I disagree. I think the main features and even the rights ratio will be very similar to past issue.